Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The new skin model can predict how chemicals might cause skin allergies.

Ancient immune and signaling pathways still regulate blood cell development.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

A new genetic model may improve treatment and diagnosis for certain inherited skin diseases.

Lgr5 and the vitamin D receptor are key in controlling skin inflammation and tumor risk in mice.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Hair growth phase in mice weakens certain immune responses.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

CMV infection increases the risk of GvHD after bone marrow transplants.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Genetically engineered mouse models help identify key pathways and targets for melanoma treatment.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.